Virus News and Research

Latest Virus News and Research

The trajectory of B-cell immunity six months after mRNA vaccination

Researchers assess SARS-CoV-2 antibodies in individuals vaccinated with a mRNA COVID-19 vaccine six months after receiving their second dose.

10 Mar 2022

WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

The National Institutes of Health has called COVID-19 testing "the key to getting back to normal." Yet testing rates have dropped nationwide, even as the Delta and Omicron variants accelerated the virus' spread.

10 Mar 2022

UQ and Moderna partner to research and develop vaccines against global public health threats

The University of Queensland has been selected as one of the first launch institutions in the world to partner with biotechnology company Moderna to research and develop vaccines to tackle the world's greatest global public health threats.

9 Mar 2022

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

The new drug nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled phase 3 clinical trial published in the New England Journal of Medicine.

9 Mar 2022

Cedars-Sinai scientists identify potential new therapy for COVID-19

Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.

9 Mar 2022

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Researchers at the University of Birmingham working in partnership with firms NitroPep Ltd and Pullman AC have developed new antimicrobial technology for air filters which can in seconds kill bacteria, fungi and viruses including SARS-CoV-2 - providing a potential solution to prevent the spread of airborne infections.

9 Mar 2022

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

A new study used glycoprotein profiling technology platform that couples high-resolution LC-MS for glycoprotein analysis in regards to COVID-19.

9 Mar 2022

Clinical trial of novel rabies vaccine in human volunteers begins in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

9 Mar 2022

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Researchers assessed the levels of neutralizing antibodies in coronavirus disease patients.

9 Mar 2022

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

A recent study evaluated the positivity rates of COVID-19 rapid antigen tests in infected individuals.

9 Mar 2022

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Researchers assessed the diabetogenic potential of SARS-CoV-2 in a single cell in vitro analysis on the pancreatic islet cells.

9 Mar 2022

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

A new study provides an overview of the use of mathematical modeling to determine severe acute respiratory syndrome coronavirus 2 kinetics.

9 Mar 2022

Rabies transmission via vampire bats identified in Brazil

In a new study, researchers evaluated the concerns regarding the hematophagous bat-borne rabies in Brazil.

9 Mar 2022

One California university has unified town and gown to fight covid. Why haven’t others?

Once a week, Lori Janich drives down the street from her office and partakes in an ongoing success story. Phone in hand to confirm her appointment, she strolls into the massive Activities and Recreation Center on the University of California-Davis campus, reaches a covid-19 testing station, swirls water in her mouth, spits into a tube, and leaves. Within a day, she receives her test result.

9 Mar 2022

The CDC’s new guidelines on covid risk and masking elicit mixed feelings

When the Centers for Disease Control and Prevention last month unveiled updated covid-19 guidelines that relaxed masking recommendations, some people no doubt sighed in relief and thought it was about time.

9 Mar 2022

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

In a recent study posted to the bioRxiv* preprint server, researchers presented the intragenomic rearrangements of β-coronaviruses (CoVs), including severe acute respiratory syndrome CoV 2 (SARS-CoV-2).

9 Mar 2022

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that the lower expression of EXOSC2 human protein safeguards from clinical coronavirus disease 2019 (COVID-19). This protective effect was via the reduced EXOSC2 expression-associated suppression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication.

9 Mar 2022

Assessment of oligonucleotides as COVID-19 treatment

A recent study posted to the bioRxiv* pre-print server assessed the ability of oligonucleotides in preventing the development of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions.

8 Mar 2022

Challenges and solutions for long-COVID

A recent study published in the Annals of Internal Medicine investigated the challenges and solutions associated with the unbiased estimation of post coronavirus disease 2019 (COVID-19) sequelae.

8 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Virus News and Research

Latest Virus News and Research

The trajectory of B-cell immunity six months after mRNA vaccination

WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

UQ and Moderna partner to research and develop vaccines against global public health threats

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

Cedars-Sinai scientists identify potential new therapy for COVID-19

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Clinical trial of novel rabies vaccine in human volunteers begins in Tanzania

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

Rabies transmission via vampire bats identified in Brazil

One California university has unified town and gown to fight covid. Why haven’t others?

The CDC’s new guidelines on covid risk and masking elicit mixed feelings

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Assessment of oligonucleotides as COVID-19 treatment

Challenges and solutions for long-COVID

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in